CRAQ — Q2 2026 Financial Report Analysis

Cal Redwood Acquisition Corp. is a blank-check company, also called a SPAC (special purpose acquisition company). It has no products, customers or employees. It raised $230 million in a May 2025 IPO, locked that money in a trust account invested in short-term US Treasury bills, and has until May 27, 2027 to find a private company to merge with. In the second quarter of 2026 it earned $2.10 million of interest on that trust and spent $383,145 on running costs, for net income of $1.73 million ($0.06 per share). As of the 10-Q filed August 17, 2026, no merger target had been announced.

At a glance

• $239.8 million in trust, or $10.43 per public share (up from the $10.00 IPO price). This is roughly what a public shareholder can claim back in cash by redeeming, so it acts as a floor under the share price as long as the money stays in trust.
• No deal yet, about 10 months left. If no merger closes by May 27, 2027, the company must wind down and return the trust money to public shareholders. Because of that deadline, management says there is "substantial doubt" about the company continuing as a going concern, which is standard wording for a SPAC with no signed deal.
• Running costs nearly tripled from Q1 ($383,145 vs $132,112), so net income fell 10% from the prior quarter even though trust interest rose. The filing does not say what the extra spending was for.

What this company actually is

A SPAC works like this: investors buy units at $10.00, the cash goes into a trust, and the sponsor (here Cal Redwood Sponsor LLC, based on Sand Hill Road in Menlo Park) looks for a private business that wants to go public by merging into the shell. When a deal is put to shareholders, each public shareholder can either keep their shares and become an owner of the merged business, or redeem: hand the shares back for their slice of the trust in cash.

Cal Redwood's terms, from the 10-Q:

• 23,000,000 public units sold at $10.00 (including the full 3,000,000-unit over-allotment), plus 660,000 private placement units bought by the sponsor and underwriters for $6.6 million.
• Each unit is one Class A share plus one right to receive one-tenth of a Class A share if a merger closes. The rights are worth nothing if no deal happens.
• The sponsor holds 7,665,900 Class B "founder" shares, bought for $25,000 in total (about $0.003 each). That is about 24% of all shares outstanding. This is where the sponsor's payoff comes from, and it is why sponsors have a strong incentive to close some deal before the deadline.
• The target must be worth at least 80% of the trust balance. The filing does not name a target industry.
• The Class A shares trade on Nasdaq; the filing's cover lists the symbol as CRA, units as CRAQU and rights as CRAQR.

The numbers

There is no revenue to report: the company states it "will not generate any operating revenues until after the completion of its initial Business Combination". All of its income is interest earned on the trust. Trust interest is listed below as its own line, not as revenue.

The year-over-year growth figures don't mean much. The IPO closed on May 27, 2025, so the trust earned interest for only about five weeks of last year's second quarter. A better comparison is with the previous quarter:

Q2 trust earnings work out to roughly a 3.5% annual rate on the balance, in line with short-term Treasury yields. Over the first half the trust grew from $235.6 million to $239.8 million, and every dollar of that growth came from interest; nothing was withdrawn.

Takeaway: For a shareholder, the reported net income matters less than two figures: $10.43 per share in trust, which is the cash value of redeeming, and the May 27, 2027 deadline. Fifteen months after the IPO there is still no announced target, and Q2 costs stepped up sharply. That could mean deal work has started, but the filing doesn't say so.

What the headline numbers hide

• The profit is not usable cash. Net income for the first half was $3.64 million, yet operating activities used $200,517 of cash. All of the $4.14 million of trust interest stays locked in the trust, which can only pay out for taxes, a completed merger or redemptions. The money the company can actually spend is the $821,425 held outside the trust, down from $1.10 million at the end of 2025.
• Unpaid bills are piling up. Accounts payable and accrued expenses rose from $74,547 at December 31 to $346,536 at June 30. Together with the jump in quarterly running costs, that points to more professional fees being incurred. The filing does not say whether they relate to a specific deal. Working capital, meaning current assets minus current liabilities, is still a $558,324 surplus. The sponsor may lend up to $2.5 million more if needed, and none has been borrowed so far.
• Big costs only arrive with a deal. A $9.2 million deferred underwriting fee is owed to the IPO banks, but only if a merger closes, scaled to how much money remains in trust after redemptions. Add the founder shares and the rights, and the shareholders who stay in after a merger end up owning less of the combined company than the $10.43-per-share trust value suggests. This is the standard SPAC dilution trade-off.
• The late-filing notice was minor. The 10-Q was due August 14, 2026. On August 17, the next business day, the company filed an NT 10-Q (Form 12b-25) citing "an unforeseen administrative delay" and filed the full 10-Q the same day. It was also the first periodic report Cal Redwood filed itself rather than through the filing agent it had used before. The notice answered "No" to whether results would change significantly from the year before, even though net income nearly tripled. That gap comes from last year's short interest period rather than any change in the business. Management concluded its disclosure controls were effective, and no subsequent events were reported.
• No adjusted figures, no one-offs this year. There is no gap between GAAP and adjusted results to explain. The only one-off item was in the prior year: $132,300 of share-based pay to director nominees in Q2 2025.

What to watch

There is no management guidance; a SPAC doesn't give any. What matters from here:

• A merger announcement. This would show up as an 8-K and Form 425 filings naming a target. It is the single event that would change the investment case, and the jump in Q2 costs is the only hint in this filing that work may be under way.
• The May 27, 2027 deadline. A SPAC with no deal close to its deadline usually asks shareholders to extend it. That vote gives holders another chance to redeem, and redemptions at that stage are often heavy.
• Running costs against cash outside the trust. At the first half's rate of spending, the $821,425 covers the time left before the deadline. Deal-related legal and audit work could use it up quickly, and the company would then need to borrow from the sponsor.
• The next 10-Q (quarter ending September 30, 2026) is due around mid-November 2026.

Units and figures are from the company's Form 10-Q for the quarter ended June 30, 2026 (filed August 17, 2026), its Q1 2026 10-Q and its Form 12b-25. Dollar amounts in tables are in USD.